United States · FDA National Drug Code directory
CEFPODOXIME PROXETIL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-095_12ee6554-adfc-4c3b-b87e-3568576359a6
- Product NDC
- 65862-095
- Form
- TABLET, FILM COATED
- Composition / generic term
- CEFPODOXIME PROXETIL
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070611
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFPODOXIME PROXETIL — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (65862-095-01) · 65862-095-01
- 20 TABLET, FILM COATED in 1 BOTTLE (65862-095-20) · 65862-095-20
- 250 TABLET, FILM COATED in 1 BOTTLE (65862-095-25) · 65862-095-25
- 1000 TABLET, FILM COATED in 1 BOTTLE (65862-095-99) · 65862-095-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →